“martin-shkreli” Archives

in
Entry Author Date Location
Fired From KaloBios, Shkreli Defends Himself Against Fraud Charges 12/21/15 National
The Day After His Arrest, Martin Shkreli Is Out At Turing Pharma 12/18/15 National
West Coast Bio Roundup: Shkreli Cuffed, KaloBios Halted & More 12/17/15 National
West Coast Bio Roundup: Gene Edit Talk, Not Poor ORIC, BioMarin Sags 12/04/15 San Francisco
West Coast Bio Roundup: Shkreli, T4 Diabetes, Cella-Done, A16Z+Bio 11/20/15 San Diego
Even With New Crowdfunding Rules, No Easy Path Forward For Biotechs 11/03/15 National
Biopharma CEOs, VCs, and Hedge Fund Managers: Fifty Shades of Greed 10/07/15 National
Crossing Sand Hill: A Q&A With Biotech Venture Vet Nina Kjellson 09/30/15 San Francisco
West Coast Biotech Roundup: Gilead, Conatus, Exelixis, and More 09/25/15 San Diego
Shkreli Implodes And Provides Hillary A Perfect Medicare Moment 09/23/15 National
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
Shkreli Leads $90M Round for New Startup, Turing Pharma 08/10/15 New York
With Asklepion Deal, Retrophin Gets a New Drug—And a Voucher 03/18/15 New York
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More 09/15/14 Boston
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
With $2M Seed, Perlstein Lab Tests Unorthodox Rare-Disease Plan 07/31/14 San Francisco
Retrophin Shares Boom Following Manchester Pharma Buyout 02/13/14 New York
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
East Coast Life Sciences Roundup: NY Genome Center, Acceleron, Bind, & More 09/20/13 Boston
Shkreli’s Retrophin Makes Hostile Bid For CA-based Transcept 09/18/13 New York
Retrophin, Headed by Controversial Hedge Fund Chief, Raises $4M 05/07/12 New York
Hard-Nosed Hedge Fund Chief Has Soft Spot for Rare-Disease Startup 04/03/12 New York
Page 2 of 2 « previous page